Tri Locum Partners LP Mersana Therapeutics, Inc. Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$3.08 - $9.55 $1.32 Million - $4.09 Million
428,307 New
428,307 $1.41 Million
Q1 2021

May 17, 2021
SELL
$15.31 - $26.52 $4.16 Million - $7.21 Million
-271,974 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$16.84 - $27.59 $4.58 Million - $7.5 Million
271,974 New
271,974 $7.24 Million

Others Institutions Holding MRSN

# of Institutions
125
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $52.5M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email